Shoulder Innovations (SI) Operating Leases (2025)
Shoulder Innovations' (SI) quarterly Operating Leases came in at $113000.0 in Q4 2025.
Analysis
Shoulder Innovations (SI) Operating Leases (2025) Analysis & Trends
Shoulder Innovations (SI) has reported Operating Leases for 1 consecutive years, with $113000.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases changed N/A year-over-year to $113000.0; the trailing twelve-month figure through Dec 2025 stood at $113000.0 (changed N/A YoY), and the FY2025 full-year result was $113000.0, changed N/A from the prior year.
- Operating Leases held at $113000.0 in Q4 2025 per SI's latest filing.
- Across five years, Operating Leases topped out at $113000.0 in Q4 2025 and bottomed at $113000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn |
| 10 | Shoulder Innovations | 412.33 Mn | 313.34 Mn | 13.44 Mn |